Procedure to stop bleeding in a brain bleed using a small plug
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial looks at a minimally invasive procedure that may stop bleeding in the space between the brain and its outer covering (a subdural hematoma). It’s being offered to people being evaluated in Canada, and the main goals are to see if the approach is safe and practical for routine use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a subdural hematoma.
- You are being evaluated in the emergency room or a neurosurgery outpatient clinic.
- You (or your substitute decision-maker, if needed) can give consent to join the study.
- The medical team cannot enroll you if consent cannot be obtained from you or your substitute decision-maker.
- You do not have a known allergy to the liquid agent used to block the bleeding vessel.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer way to treat subdural hematoma—a bleeding problem inside the brain. After surgery to drain the blood, you'll receive an additional minimally invasive procedure (middle meningeal artery embolization) using a new device called NeoCast to help prevent the bleeding from coming back.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
This study tests a procedure called middle meningeal artery embolization for people with a confirmed chronic subdural hematoma (a long-lasting bleed near the brain). It may help by reducing the blood supply to the area and improving symptoms after symptoms start or worsen.
This study follows patients with chronic subdural hematoma (a type of bleeding around the brain) who receive a procedure called middle meningeal artery embolization, which reduces blood flow to prevent rebleeding. Researchers will track your recovery with imaging and clinical assessments to understand how well this treatment works.
This trial looks at how well a procedure called middle meningeal artery embolization works for people with chronic subdural hematoma (a collection of old blood on the brain's surface). It uses specific materials to block the blood supply to the hematoma, which may help the body reabsorb it without surgery.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
Hear when a new Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.